Skip to main content

Opiate Dependence News

Related terms: Opioid Dependence, Opioid Use Disorder

Inmates Less Likely To OD After Release If Provided Opioid Addiction Meds In Jail

FRIDAY, Sept. 12, 2025 — County jail inmates who receive medication to treat their opioid addiction have a lower risk of overdose after their release, a new study reports. They’re also significantly m...

Medicaid Crucial In Battling Opioid Epidemic

TUESDAY, Sept. 9, 2025 — Medicaid serves a key role in helping opioid addicts get the treatment they need, a new study says. Prescription rates for the anti-opioid medication buprenorphine increased m...

One in 10 Undergoing Early Cancer Surgery Have New Persistent Opioid Use

MONDAY, Sept. 8, 2025 – More than one in 10 veterans undergoing surgery for early-stage cancer develop new persistent opioid use, according to a study published online Sept. 8 in Cancer. Marilyn M....

59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024

TUESDAY, Sept. 2, 2025 – From 2021 to 2024, 59.0 percent of overdose deaths involved stimulants, according to research published in the Aug. 28 issue of the U.S. Centers for Disease Control and...

It's Still Tough to Find a Key Anti-Opioid Treatment, Buprenorphine, at U.S. Pharmacies

WEDNESDAY, Sept. 3, 2025 — One of the most effective medications for treating opioid addiction is still hard to find at U.S. pharmacies, according to a new study. Only 2 in 5 retail pharmacies c...

Buprenorphine Available at 39.4 Percent of U.S. Pharmacies in 2023

WEDNESDAY, Sept. 3, 2025 – From 2017 to 2023, there was an increase in buprenorphine availability overall, reaching 39.4 percent in 2023, according to a study published online Sept. 2 in Health...

AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children

TUESDAY, Aug. 19, 2025 – A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for five or more days, according to a clinical report from the...

FDA Requiring Stronger Safety Labels for Opioid Medications

MONDAY, Aug. 4, 2025 – The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain medications to better highlight the risks of long-term use,...

FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products

TUESDAY, July 29, 2025 – The U.S. Food and Drug Administration is recommending that certain products containing 7-hydroxymitragynine (7-OH) – an illegal opioid easily accessible in...

Stigma of Substance Use Disorder Varies by Condition, Provider

WEDNESDAY, July 30, 2025 – Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in Addiction. Carrigan L....

FDA Medwatch Alert: FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers

July 29, 2025 – The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action to control certain...

Substance Use Disorder Linked to Higher Risk for Unplanned Readmissions

TUESDAY, July 29, 2025 – People with any type of substance use disorder (SUD) face a higher risk for having an unplanned, 30-day hospital readmission compared with those without SUD, according to a...

Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery

TUESDAY, July 29, 2025 – Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing anterior cruciate...

Doctor's Advice Can Reduce Opioids Taken After Surgery

MONDAY, July 28, 2025 — Some wise counsel in advance can reduce the amount of opioid painkillers a patient takes after orthopedic surgery, new clinic trial results show. Knee surgery patients were m...

FDA Sends Warning Letters to Companies Selling Illegal Opioid Compound

TUESDAY, July 15, 2025 – The U.S Food and Drug Administration has issued seven warning letters to companies illegally marketing products containing 7-hydroxymitragynine (7-OH), which is found in...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Opiate Withdrawal, Opiate Dependence - Maintenance, Drug Dependence

Related drug support groups

Suboxone, naltrexone, Subutex, buprenorphine, Vivitrol, Sublocade, buprenorphine / naloxone